Navigation Links
VA Vet Centers Coming to 39 Communities
Date:7/9/2008

Peake: Provide Counseling for All Combat Veterans

WASHINGTON, July 9 /PRNewswire-USNewswire/ -- Combat veterans will receive readjustment counseling and other assistance in 39 additional communities across the country where the Department of Veterans Affairs (VA) will develop Vet Centers by fall 2009.

"Community-based Vet Centers -- already in all 50 states -- are a key component of VA's mental health program," said Dr. James B. Peake, Secretary of Veterans Affairs. "I'm pleased we can expand access to bring services closer to even more veterans, including screening and counseling for post-traumatic stress disorder."

The existing 232 centers conduct community outreach to offer counseling on employment, family issues and education to combat veterans and family members, as well as bereavement counseling for families of service members killed on active duty and counseling for veterans who were sexually harassed on active duty.

Vet Center services are available at no cost to veterans who experienced combat during any war era. They are staffed by small teams of counselors, outreach workers and other specialists, many of whom are combat veterans. The Vet Center program was established in 1979 by Congress, recognizing that many Vietnam veterans were still having readjustment problems.

The centers have hired 100 combat veterans who served in Iraq and Afghanistan as outreach specialists, often placing them near military processing stations, to brief servicemen and women leaving the military about VA benefits.

VA's 2009 budget proposal seeks $20 million more than this year's budget for Vet Centers, to include operating and leasing space for the new centers. Eighteen of the counties that will have new centers already have one or more; the other 21 do not.

A list of the new Vet Center locations is below.

Communities Receiving New VA Vet Centers

Alabama - Madison

Arizona - Maricopa

California - K
'/>"/>

SOURCE U.S. Department of Veterans Affairs
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
2. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
3. Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers
4. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
5. Service-to-Sales Transformation at Contact Centers Hinges on Soft Skills
6. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
7. Community Health Centers Reveal Specific Ramifications of The Medicaid Citizenship and Identification Documentation Requirements
8. Commercial Insurers Reimbursement Rate to New Yorks Community Health Centers Jeopardizes Care
9. Pennsylvania Trauma Systems Foundation Accreditation Status for Trauma Centers
10. Vangent, Inc. Wins Spot on Centers for Medicare & Medicaid Services Enterprise System Development Contract
11. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...e University College of Medicine research team led...layer of regulation in the cell division cycle, wh...ay cancer begins. , Wang, an assistant professor..., said the findings will lead to an improved abili... of new drugs that kill cancer cells by inhibiting...
(Date:11/21/2008)...ewswire/ -- The Generic,Pharmaceutical Associatio...om,GPhA President and CEO Kathleen Jaeger regardi...on "Emerging Health Care Competition and Consumer ...onducting this roundtable demonstrates the,growin...ess to safe and,affordable biogenerics sooner rat...
(Date:11/21/2008)...USNewswire/ -- New research at West Virginia Univ... tobacco product aimed at young adults is catching...ds, Camel Snus - touted as a socially acceptable w...gh levels of nicotine. , , "Camel Snus cont..." said Bruce Adkins of the state Division of Tobac...
(Date:11/21/2008)...re-FirstCall/ -- Today, prescription drugs are the... 88 percent of patients suffering chronic conditio...onic condition account for 96 percent of all presc...l costs. A proprietary new pharmacy model develop.... (NYSE: MHS ) significantly reduces critical ga...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6
...h officials are all set to oil the wheels of retai...opose new regulations to allow for the operation o...lso encourage not-for-profit hospitals, community ... basic medical services. The proposed changes wer...
...ntified the first gene that is linked to Restless ...er that affects millions of people worldwide . RL...ering need to move the legs and is also a major ca...sleep disturbance. We now have concrete evidence t...
...from heart disease among younger Britons is slowin... research published ahead of print in the journal ...nary artery heart disease in England and Wales bet...gures.They used the data to calculate heart diseas...
...f more than a thousand prisoners has failed to sol...e and prisoner rehabilitation programmes, said th...niversary of the Ministry of Justices introduction...lleviate the overcrowding crisis in English and We...
Other Medicine News:Health News:Retail Health Clinics Start Shop 2Health News:Gene Linked With Restless Leg Syndrome Spotted Out 2Health News:Disquieting Slow Down in Heart Disease Deaths Among Under 55s 2Health News:Prison Healthcare Continues to Fail Despite Emergency Measures, Warns BMA 2
(Date:11/19/2008)...istical significance , , ISELIN, N.J., Nov.... (Nasdaq: PARS ) today announced results from it...ion (NE) drug delivery technology formulated with ...-center, randomized, double-blinded, placebo-contr...he Company,s 3% Diclofenac Diethanolamine NanoEmul...
(Date:11/18/2008)...all/ -- NeuroDiscovery Ltd (ASX:,NDL), a specialt...nt Company,and Sosei Group Corporation ("Sosei";...l biopharmaceutical company, today announce that N...linical efficacy data for NSL-043/SD118.,This inv...pathic pain and has,successfully completed Phase ...
(Date:11/18/2008)...gnosed, elderly AML patients , , PRINCETON,...cals today announced that the first patient has be...of CPX-351 (Cytarabine:Daunorubicin) Liposome Inje...id leukemia (AML). , , The first patient wa...al College of Cornell University and New York Pre...
(Date:11/12/2008)...Watson, Marilyn & James Simons and,Sherry Lansing ... 12 J. Craig Venter,Ph...Institute (JCVI), was,awarded the Double Helix Med...vember 6th at a gala event in New York City., Dr.... Dr. James D.,Watson for making each of their indi...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2ASTRO selects pediatric oncologist as 2008 honorary member 25838 1ASTRO selects pediatric oncologist as 2008 honorary member 25838 2Combination Therapy Helps to Combat Myeloma 25834 1Combination Therapy Helps to Combat Myeloma 25834 2Combination Therapy Helps to Combat Myeloma 25834 3Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York 7358 1Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York 7358 2Iowa State University researcher shows proteins have controlled motions 4624 1Iowa State University researcher shows proteins have controlled motions 4624 2
...patients treated with VELCADE, cyclophosphamide,a...ne 28, 2007 /PRNewswire-FirstCall/ -- Millennium,P...ation of results,from clinical trials of VELCADE b... / complete response(1) (CR) rates in previously,t...ngs were,presented at the prestigious 11th Interna...
...Synagis Decreases Incidence of Recurrent Wheeze by...Md., June 29, 2007,/PRNewswire-FirstCall/ -- Abbot...tudy, published in the July issue of Journal of,Pe...palivizumab),may reduce recurrent wheezing in prem...study showed that premature infants without,chroni...
Other Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5
Healon vitreous aspirating cannula, 21 gauge.
Flexible silicone tip cannula allows atraumatic access through retinal tear or hole for aspiration of subretinal fluids. Silicone tube extends 6mm beyond end of cannula. Luer lock hub for easy, sec
Ultra thin wall .90 mm (20 g) cannula allows maximum flow rate, 6 mm in length. Cannula beveled for easy insertion through sclerotomy. 3201 has 16 cm (6 in) high pressure PVC tubing to allow injectio
...ective line of compact CO2 systems combines portab...ature an extremely accurate laser beam, as well as...cially advantageous for small operating theatres a.... Use of special contact tips and accessories allo...
Medicine Products: